secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001384101-22-000015
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte appoints Jonathan Wygant as CAO; Beverly Alley to depart in June 2022
------------------------------------------------------------------------------

- Jonathan Wygant named VP & Chief Accounting Officer, effective March 1, 2022.
- Wygant receives $350k base salary, 35% bonus target, 24k stock options, 12k RSUs.
- Beverly Alley transitions to VP, Accounting through June 30, 2022, then departs.
- Alley receives 3 months' salary and COBRA continuation upon separation.
- Wygant previously served as corporate controller at Biosplice Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/0001384101-22-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410122000015/vcyt-20220219.htm
  HTML page:      https://secwatch.observer/filing/0001384101-22-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer